Treatment Sequence May Impact Pancreatic Cancer Survival Treatment Sequence May Impact Pancreatic Cancer Survival
The sequence of systemic therapies for advanced pancreatic ductal adenocarcinoma can affect overall patient survival, a new analysis suggests.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 29, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

What Is the Status of Medically Assisted Death in Mexico? What Is the Status of Medically Assisted Death in Mexico?
Euthanasia is illegal in Mexico, but many patients and doctors, and much of the public, support the right to die with dignity.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 26, 2024 Category: Cancer & Oncology Tags: Family Medicine/Primary Care Source Type: news

Study Validates Breast Recurrence Score Across Ethnic Groups Study Validates Breast Recurrence Score Across Ethnic Groups
A recent study validated the predictive biomarker ' s effectiveness in guiding treatment decisions for diverse groups.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 25, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Europe Is Facing a Pancreatic Cancer Emergency Europe Is Facing a Pancreatic Cancer Emergency
People living in Western Europe are more likely to develop pancreatic cancer than those living anywhere else in the world.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 25, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

New Strategy Improves Early-Stage Ovarian Cancer Detection New Strategy Improves Early-Stage Ovarian Cancer Detection
A new screening approach demonstrated positive predictive value of 50% for ovarian cancer and 74% for any cancer, with most cancers detected in stages I and II.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 25, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

US FDA Examined 22 Cases Of Cancers in CAR-T Probe -officials US FDA Examined 22 Cases Of Cancers in CAR-T Probe -officials
The U.S. Food and Drug Administration has been looking into 22 cases of T-cell cancers that occurred after treatment with CAR-T, two top FDA officials said on Wednesday,...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 24, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Dana-Farber May Retract, Correct Over 30 Cancer Papers Dana-Farber May Retract, Correct Over 30 Cancer Papers
Dana-Farber Cancer Institute is investigating allegations of data manipulation in dozens of research papers, some of which were authored by high-profile investigators.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 24, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Will New Lung Cancer Screening Guidelines Save More Lives? Will New Lung Cancer Screening Guidelines Save More Lives?
Recent changes to lung cancer screening will expand the eligible population, but experts cautioned that long-standing barriers to screening may mean that screening rates remain low.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 24, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Immunotherapy Combo Wins Big on PFS in First-Line Mets CRC Immunotherapy Combo Wins Big on PFS in First-Line Mets CRC
First-line nivolumab plus ipilimumab led to significantly better 2-year PFS in metastatic CRC than chemotherapy as well as pembrolizumab monotherapy.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 23, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

J & J Agrees to Resolve 42 U.S. States' Talc Investigations J & J Agrees to Resolve 42 U.S. States' Talc Investigations
Johnson& Johnson on Tuesday said it had reached a tentative settlement to resolve probes by U.S. states into whether it misled consumers about the safety of its talc...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 23, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

US FDA Seeks'boxed Warning' for CAR-T Cancer Therapies US FDA Seeks'boxed Warning' for CAR-T Cancer Therapies
The U.S. health regulator said on Monday companies will be required to add a serious warning on the prescribing information for cancer therapies known as CAR-T, made by...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 23, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

No Compelling Evidence of Pancreatic Cancer Risk With GLP-1s No Compelling Evidence of Pancreatic Cancer Risk With GLP-1s
Up to 7 years treatment with GLP-1 receptor agonist in patients with type 2 diabetes didn ' t seem to increase pancreatic cancer risk in a large population-based cohort study.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 22, 2024 Category: Cancer & Oncology Tags: Gastroenterology Source Type: news

Gilead's Trodelvy Fails to Meet Main Goal in Lung Cancer Trial Gilead's Trodelvy Fails to Meet Main Goal in Lung Cancer Trial
Gilead Sciences said on Monday its drug, Trodelvy, failed to significantly improve survival for previously treated patients with advanced non-small cell lung cancer (NSCLC)...Reuters Health Information (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 22, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Adaptive SABR Boost Shows Promise in Advanced NSCLC Adaptive SABR Boost Shows Promise in Advanced NSCLC
Radiation dose-escalation combined with stereotactic ablative radiotherapy may improve locoregional control in patients with NSCLC.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 19, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Source Type: news

Call to Action: Fix the Drug Shortages to Save Patients Call to Action: Fix the Drug Shortages to Save Patients
Dr Maurie Markman discusses widespread shortages of anticancer chemotherapeutic agents.Medscape Oncology (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - January 18, 2024 Category: Cancer & Oncology Tags: Hematology-Oncology Commentary Source Type: news